{"chebi_id":"5138","chebi_name":"fluvoxamine","chebi_synonyms":["(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime","fluvoxamina","fluvoxaminum","Fluvoxamine","2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine","O-(2-aminoethyl)-N-{(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}hydroxylamine"],"diffprof_id_observed":["MTBLS2145_0001_00000029","MTBLS2384_0002_00000005","MTBLS3750_0001_00000006","MTBLS673_0001_00000006"],"diffprof_id_var_observed":[],"inchikey":"CJOFXWAVKWHTFT-XSFVSMFZSA-N","inn_name":"fluvoxamina","iupac_name":"(1<i>E</i>)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one <em>O</em>-(2-aminoethyl)oxime","num_study_observed":4,"reactome_ids":["R-HSA-112311","R-HSA-112315","R-HSA-112316","R-HSA-1643685","R-HSA-380615","R-HSA-5663205","R-HSA-9679191","R-HSA-9679506","R-HSA-9824446"],"reactome_names":["Neurotransmitter clearance","Transmission across Chemical Synapses","Neuronal System","Disease","Serotonin clearance from the synaptic cleft","Infectious disease","Potential therapeutics for SARS","SARS-CoV Infections","Viral Infection Pathways"],"study_id_observed":["MTBLS2145","MTBLS2384","MTBLS3750","MTBLS673"],"study_id_var_observed":[],"synonym_name":"Fluvoxamine"}